The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
about
Biomarkers for nutrient intake with focus on alternative sampling techniquesADMA/SDMA in elderly subjects with asymptomatic carotid atherosclerosis: values and site-specific association.Extensive alterations of blood metabolites in pediatric cerebral malaria.The issue of plasma asymmetric dimethylarginine reference range - A systematic review and meta-analysisHuman dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.Endothelial dysfunction in chronic inflammatory diseasesMetabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndromeAsymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease.A systematic review of metabolite profiling in gestational diabetes mellitus.Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.Plasma levels of dimethylarginines in preterm very low birth weight neonates: its relation with perinatal factors and short-term outcome.Aging of the nitric oxide system: are we as old as our NO?Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac HypertrophyDysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease.The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease.Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris.Nitric Oxide-Related Biological Pathways in Patients with Major DepressionProtective effect of ginseng against gamma-irradiation-induced oxidative stress and endothelial dysfunction in rats.Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming.Arginine de novo and nitric oxide production in disease states.Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.Organic nitrates favor regression of left ventricular hypertrophy in hypertensive patients on chronic peritoneal dialysis.Ageing/Menopausal Status in Healthy Women and Ageing in Healthy Men Differently Affect Cardiometabolic ParametersSerum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort studyRole of chitotriosidase (chitinase 1) under normal and disease conditions.Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol - Differences or Similarities?The role of profilin-1 in endothelial cell injury induced by advanced glycation end products (AGEs)Hepatic extracellular signal-regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunctionEffect of trelagliptin on vascular endothelial functions and serum adiponectin level in patients with type 2 diabetes: a preliminary single-arm prospective pilot study12-months metabolic changes among gender dysphoric individuals under cross-sex hormone treatment: a targeted metabolomics study.Association between endothelial dysfunction and frailty: the Toledo Study for Healthy Aging.Association of angiopoietin-2 and dimethylarginines with complicated course in patients with leptospirosis.Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients.Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.Asymmetric dimethylarginine, endothelial dysfunction and renal diseaseDetrimental role of humoral signalling in cardio-renal cross-talk.
P2860
Q26739783-206BB99F-ED63-4FE3-B81C-86E17336E9DCQ33580684-19190D1E-934F-4566-8825-1318A468FF0FQ33584763-38298047-ED0C-4227-A0AD-7F0D3CBB8131Q33664224-D2EEAD7A-F93D-4ABF-A4DB-22A476E40C93Q33767571-23C60121-D92C-45DA-A4CC-C875941EBCC2Q34008329-007E1A01-BF56-464C-B43E-64774CD7B997Q34072179-BE8C1464-D33E-4F21-8521-D289AB1B4C14Q34161527-1E8A86B0-7220-47E5-AF40-631918BBDC66Q34217527-AE3271C6-9D7F-4902-90A5-FD841CCCF74AQ34458995-49791B09-889F-4A31-9E75-692B97C24F0FQ34950263-646F73DF-1C9E-40CC-9B1F-56F283F74EDEQ35016382-C9EC56A5-17AE-4898-A92D-67FAF0A00348Q35026305-4348E4F9-1521-42E8-8B1C-FE91D37E5350Q35686992-28269046-D10B-41B2-B899-B0E53925F86DQ35757606-CE1D6576-6065-43D3-994C-ECDC9124AB05Q35760391-28A707B2-3506-449D-8B16-BB81F8885F0BQ35869541-0B3F182C-D8AF-4A97-819B-1602306ADAEBQ35966113-28F57894-9B48-4647-880B-0E95CEEC5B4BQ36296008-454CA374-50BA-4E21-862E-1778156880CCQ36325484-FD1BEA9A-2F60-4EED-A83F-B9646BDA4D36Q36432504-A01675EF-D1C1-4337-8A42-A3F59A42C473Q36454194-D9253B4C-652A-48A7-B7DD-346C31DCAF22Q36481807-DC2E57FD-23FA-4E11-B49B-26F4199096D9Q36590001-1EDCCED3-B9CB-4712-9946-AB221254A566Q36610624-BB00504E-5763-4AAF-8E9B-1718480D5994Q36625589-970A8734-4C23-4EB9-8B9E-7913835A9B69Q36630259-F4083FEB-C0F6-4A9C-8782-3A9ED670F3C5Q37041316-A2E8ECB1-7D6D-4D7E-8318-D1E34EC4E92FQ37279201-C845F59D-FF21-4A2A-98D3-7E00A9696380Q37310401-008483DC-DBFF-4D36-881E-C3A3DD23F60EQ37394740-4B61E3B4-7E1A-4F74-A08D-4DD9D53B74DDQ37408529-09B512AB-0611-43FE-9B75-6BD2CD63A81FQ37471123-3F37C55A-162B-4F98-96DB-9C10CCE26F18Q37534510-58AD0E7C-FE44-44DD-B32E-53967AE6547EQ37597536-DA88905E-209C-4373-8505-16194C3A5AC7Q37602513-3618131A-EE86-4FF5-A4F8-0CB9C0619F32Q37681556-8F433957-6137-4F9D-87A8-3CEF6F2ECA85Q37686803-AE60825F-CDFA-414E-B908-637876F582B2Q38056493-592803DB-319A-456D-9CFB-7462780F9EF7Q38180840-E575E3E7-19D3-4834-8D1B-B509A9D5264B
P2860
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The Role of Asymmetric Dimethy ...... ion and Cardiovascular Disease
@ast
The Role of Asymmetric Dimethy ...... ion and Cardiovascular Disease
@en
type
label
The Role of Asymmetric Dimethy ...... ion and Cardiovascular Disease
@ast
The Role of Asymmetric Dimethy ...... ion and Cardiovascular Disease
@en
prefLabel
The Role of Asymmetric Dimethy ...... ion and Cardiovascular Disease
@ast
The Role of Asymmetric Dimethy ...... ion and Cardiovascular Disease
@en
P2093
P2860
P1476
The Role of Asymmetric Dimethy ...... ion and Cardiovascular Disease
@en
P2093
Latika Sibal
Philip D Home
Rainer H Boger
Sharad C Agarwal
P2860
P356
10.2174/157340310791162659
P577
2010-05-01T00:00:00Z